FDA recall record

EVR FOODS "LAVVA Blueberry Dairy Free Pili Nut Yogurt recall — FDA F-0287-2021

Product may contain mold.

Class IIclassification
F-0287-2021official record ID
Feb 17, 2021report date

Recall record at a glance

Official recordF-0287-2021
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmEVR FOODS Inc.
Report dateFeb 17, 2021
Recall initiation dateJan 6, 2021
Quantity" 806 cases (9,672 units)
LocationWarwick, NY, United States

Official product description

"LAVVA Blueberry Dairy Free Pili Nut Yogurt. NO SUGAR ADDED. NET WT 5.3OZ (150g) ***KEEP REFRIGERATED***DISTRIBUTED BY EVR FOODS INC. NEW YORK, NY 10010"

Why the product was recalled

Product may contain mold.

Distribution information

CO, OR, MD, CA, VA, FL, IA, GA, NH, CT, NY, NJ, TX, WA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.